PT-141PT-141
Activates brain pathways involved in sexual desire and arousal.
From interest to treatment
Complete a short medical intake.
A licensed clinician reviews your history and determines if treatment is appropriate.
If appropriate, your clinician prescribes your treatment and dosage.
Your medication is fulfilled through a licensed pharmacy.
We monitor your progress and adjust as needed.

Emotional connection and sexual health are influenced by a complex interaction of hormones, physical health, stress, and relationships. Oxytocin plays a role in several of these processes, making it an area of interest for individuals exploring the biological factors behind intimacy and emotional health.
Emotional closeness and connection can shift during different stages of life or relationships. Oxytocin plays an important role in the brain's bonding and attachment systems, influencing how we experience affection, trust, and closeness with others.
Physical touch and affection are important components of intimacy and emotional health. Oxytocin is naturally released during moments of physical closeness and participates in the body's neurological and hormonal responses to affectionate touch.
Sexual desire, arousal, and satisfaction are influenced by a combination of hormones, emotional health, and nervous system activity. Oxytocin participates in aspects of sexual response, including arousal and orgasm, making it relevant to understanding the biology of sexual health.
Stress, fatigue, and emotional strain can influence how individuals experience intimacy and connection. Oxytocin interacts with the brain's stress-response systems and plays a role in emotional processing and social behavior, highlighting the connection between emotional health and physical intimacy.
Discover more specialized treatments and services offered at Fountain
Frequently Asked Questions
Oxytocin is a naturally occurring hormone that plays a role in sexual function, bonding, emotional connection, and social behavior, in addition to its established roles in childbirth and breastfeeding. Because it influences both the body and the brain, oxytocin has been studied for its potential effects on intimacy, arousal, and connection. Those effects are not the same for everyone, so Fountain considers oxytocin in the context of the specific concern being treated rather than assuming it will create a predictable emotional or sexual response.
Some clinicians consider compounded oxytocin in selected patients experiencing concerns involving sexual function, intimacy, or related symptoms. Before doing so, Fountain looks at other potential contributors such as sex hormones, medications, mental health, stress, sleep, physical health, pain, and relationship context. Low desire or difficulty with intimacy should not automatically be reduced to an oxytocin problem.
Oxytocin may play a role in sexual response, arousal, and intimacy, but its effects vary from person to person. Low desire or sexual dysfunction can also be influenced by hormones, stress, mood, medications, relationship factors, sleep, and physical health. Because of that, Fountain considers oxytocin as one potential option within a broader evaluation rather than as a universal treatment for low libido or sexual dysfunction.
Timing depends on the formulation, route, dose, and reason the medication is being used. Your clinician will provide instructions for the specific formulation you receive. Not noticing an immediate emotional, sexual, or bonding effect does not mean the dose should be increased. The relevant outcome should be defined before treatment and evaluated over time.
Potential side effects vary based on formulation and route. Symptoms can include headache, nausea, dizziness, flushing, or other physical effects. Because oxytocin can influence multiple physiological systems, unusual cardiovascular symptoms, significant mood changes, or other concerning reactions should be discussed with your clinician. Any medication affecting central or hormonal pathways should be evaluated in the context of the rest of your health.
Clinically reviewed by
Last reviewed: October 2026
Dr. Doreen Zarfati is Chief Medical Officer at Fountain Health NYC and a double board-certified psychiatrist. Her work spans mental health, longevity, metabolism and sexual health, with a particular interest in how biological and clinical factors can influence psychiatric symptoms and treatment response. At Fountain, Dr. Zarfati provides clinical oversight of Fountain’s care models, reviewing and approving them for clinical use and guiding how they are applied in patient care. Her work in IV ketamine focuses on neuroplasticity, emotional processing and the thoughtful integration of emerging treatments into structured clinical care. Her approach is individualized, collaborative and grounded in measurable response, with treatment evolving as the patient’s clinical picture changes.
Looking for more answers?
Explore our full FAQ library for common questions about mental health, ketamine, weight management, hormones, sleep, nutrition, billing, and more.

Compounded medications are available only to patients who are evaluated by a licensed healthcare provider and receive a prescription when medically appropriate. Prescriptions for compounded medications are filled and dispensed by a licensed compounding pharmacy. Compounded medications are not FDA-approved, and the FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed. Individual results may vary. Product images are for illustrative purposes only and may not reflect the actual medication, packaging, vial, or dosage dispensed.